Literature DB >> 1664445

The role of endogenous eicosanoids in rabbit-intraocular inflammation.

P S Kulkarni1.   

Abstract

The role of endogenously released eicosanoids in intraocular inflammation was assessed in two rabbit models. The models were: (1) paracentesis in which only breakdown of blood-aqueous barrier (BAB) occurs and (2) uveitis induced by endotoxin in which the disruption of the BAB and polymorphonuclear leukocyte infiltration are the predominant events. Indomethacin (a specific cyclooxygenase inhibitor) applied topically inhibited both the disruption of the BAB and increased levels of aqueous humor 6-keto-Prostaglandin (PG)F1 alpha. However, indomethacin and flurbiprofen applied topically and BWA4C or BWA218C (both selective lipoxygenase inhibitors) given parenterally, did not inhibit BAB response in endotoxin-induced uveitis. The cyclooxygenase inhibitors attenuated PGE2 release into aqueous humor. The 5-lipoxygenase inhibitors reduced the PMN infiltration as well as LTB4 release into aqueous humor. However, myeloperoxidase activity (an index for PMN chemotaxis) in iris-ciliary body was not affected by these drugs. Furthermore, concentrations of LTB4 in aqueous humor after paracentesis and uveitis-induced by endotoxin were similar, although in the former model there was no leukocyte infiltration, but in the latter model this leukocyte response was predominant. The results of this study suggest that locally released autocoids may not initiate ocular inflammation and other mediators such as cytokines may be involved in the inflammatory responses of the rabbit eye. We tried to detect IL-1 activity in aqueous humor following endotoxin. However, we could not detect the presence of IL-1-like activity, possibly because endotoxin also releases PGs, which inhibit IL-1 bioassay.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1664445

Source DB:  PubMed          Journal:  J Ocul Pharmacol        ISSN: 8756-3320


  6 in total

1.  Anti-inflammatory effects of specific cyclooxygenase 2,5-lipoxygenase, and inducible nitric oxide synthase inhibitors on experimental autoimmune anterior uveitis (EAAU).

Authors:  Nalini S Bora; Jeong-Hyeon Sohn; Puran S Bora; Henry J Kaplan; Prasad Kulkarni
Journal:  Ocul Immunol Inflamm       Date:  2005 Apr-Jun       Impact factor: 3.070

2.  Explorative study of interleukin levels in the human cornea.

Authors:  J Becker; S Salla; U Dohmen; C Redbrake; M Reim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-12       Impact factor: 3.117

3.  Comparative lipidomic analysis of inflammatory mediators in the aqueous humor and tear fluid of humans and rabbits.

Authors:  Dmitry V Chistyakov; Nadezhda V Azbukina; Alina A Astakhova; Sergei V Goriainov; Viktor V Chistyakov; Veronika V Tiulina; Viktoriia E Baksheeva; Vladislav I Kotelin; Elena V Fedoseeva; Andrey A Zamyatnin; Pavel P Philippov; Olga A Kiseleva; Alexander M Bessmertny; Ivan I Senin; Elena N Iomdina; Marina G Sergeeva; Evgeni Yu Zernii
Journal:  Metabolomics       Date:  2020-02-12       Impact factor: 4.290

4.  Treatment with melatonin after onset of experimental uveitis attenuates ocular inflammation.

Authors:  P H Sande; D Dorfman; D C Fernandez; M Chianelli; A P Domínguez Rubio; A M Franchi; D M Silberman; R E Rosenstein; D A Sáenz
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

5.  The Therapeutic Benefits of Nanoencapsulation in Drug Delivery to the Anterior Segment of the Eye: A Systematic Review.

Authors:  Madhavi Bhandari; Sanko Nguyen; Mazyar Yazdani; Tor Paaske Utheim; Ellen Hagesaether
Journal:  Front Pharmacol       Date:  2022-05-13       Impact factor: 5.988

6.  Topical ophthalmic NSAIDs: a discussion with focus on nepafenac ophthalmic suspension.

Authors:  Bruce I Gaynes; Anne Onyekwuluje
Journal:  Clin Ophthalmol       Date:  2008-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.